And whilst HRD is detectable in CRC using next generation sequencing and DNA SNP array methodologies [8], with the frequency of BRCA1 and BRCA2 mutations for CRC in the order of 0.2–2.8%, BRCA mutations are not common molecular alterations in this cancer [14,15,16]. This evidence concerns the gene BRCA1 and colorectal carcinoma.